CYTEK BIOSCIENCES INC

Cytek Biosciences Reports Third Quarter 2024 Financial Results

05 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

30 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

29 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

18 9 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Announces Resignation of Chief Operating Officer Chris Williams

12 9 2024 15:20:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

21 8 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

08 8 2024 16:05:01 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports Second Quarter 2024 Financial Results

06 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

30 7 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

30 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program

06 6 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

30 5 2024 16:05:03 提供 Nasdaq GlobeNewswire

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

28 5 2024 17:30:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

20 5 2024 17:30:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports First Quarter 2024 Financial Results

08 5 2024 16:05:53 提供 Nasdaq GlobeNewswire

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

30 4 2024 17:30:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

29 4 2024 09:00:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Names William McCombe Chief Financial Officer

19 3 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

07 3 2024 17:30:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

28 2 2024 17:05:36 提供 Nasdaq GlobeNewswire